Conferences

Talks

  1. Shu DY, Lovicu FJ. Bone morphogenetic protein (BMP)-7 modulates TGFβ-induced epithelial-mesenchymal transition (EMT) of lens epithelial cells: a novel way of blocking cataract [Abstract]. Bosch Young Investigator Seminar Series, September 2016 (University of Sydney) (Link)
  2. Shu DY, Lovicu FJ. EGFR signalling promotes TGFβ-dependent epithelial-mesenchymal transition (EMT) in the lens [Abstract]. Bosch Young Investigators Annual Symposium, December 2016 (University of Sydney), won award for outstanding oral presentation (Link)
  3. Shu DY, Lovicu FJ. TGFβ transactivates EGFR-signalling during epithelial-mesenchymal transition (EMT) of lens epithelial cells [Abstract]. Asia-ARVO Biennial Meeting and Translational Vision Summit, February 2017 (Brisbane, Australia) (Link)
  4. Shu DY, Lovicu FJ. Bone morphogenetic protein (BMP)-7 modulates TGFβ-induced epithelial-mesenchymal transition (EMT) of lens epithelial cells [Abstract]. Annual HDR Save Sight Institute Student Symposium Vision Science and Ophthalmology, March 2017 (Save Sight Institute, Sydney Eye Hospital, University of Sydney) (Link)
  5. Shu DY, Lovicu FJ. TGFβ transactivates EGFR-signalling during epithelial-mesenchymal transition (EMT) of lens epithelial cells [Abstract]. Australian and New Zealand Cell and Developmental Biology Meeting, April 2017 (Lowy Building, University of New South Wales) (Link)
  6. Shu DY, Lovicu FJ. EGFR signalling promotes TGFβ-dependent epithelial-mesenchymal transition (EMT) in lens [Abstract]. Australian Society for Medical Research (ASMR) NSW Annual Scientific Meeting, June 2017 (Westmead Hospital); won the Sydney Medical School Award for outstanding achievement in research in the oral presentation category, AUD$500 prize money (Link)
  7. Shu DY, Lovicu FJ. Inhibition of EGFR signaling antagonises TGFβ-driven epithelial-mesenchymal transition (EMT) in lens epithelial cells [Abstract]. The European Molecular Biology Laboratory (EMBL) Australia Postgraduate Symposium, November 2017 (Garvin Institute, Sydney, Australia) (Link)
  8. Shu DY, Lovicu FJ. EGF potentiates TGFβ-induced epithelial-mesenchymal transition (EMT) in lens epithelial cells by enhancing EGFR signaling [Abstract]. ARVO Annual Meeting, May 2018 (Honolulu, Hawaii) (Link)
  9. Shu DY, Lovicu FJ. EGF potentiates TGF-beta-induced epithelial-mesenchymal transition in lens by enhancing EGF receptor signaling [Abstract]. XXIIII Biennial Meeting of the International Society for Eye Research (ISER), September 2018 (Belfast, Ireland) (Link)
  10. Shu DY, Lovicu FJ. Exacerbation of Transforming Growth Factor-Beta (TGFβ)-induced fibrotic cataract using epidermal growth factor (EGF): a novel mechanism in the pathogenesis of posterior capsular opacification (PCO) [Abstract]. American Academy of Optometry Annual Meeting, November 2018 (San Antonio, Texas)

 

Posters

  1. Shu DY, Go R, Munoz-Erazo Luis, Madigan M. Expression of histone deacetylases in human choroidal melanocytes, and conjunctival and uveal melanoma [Abstract] Clinical and Experimental Ophthalmology AOVSM Annual Scientific Congress, October 2011 (Canberra, Australia) (Link)
  2. Ong K, Shu DY. Evaluating the discrepancy between autorefraction and subjective refraction may guide intraocular lens power selection for cataract surgery in eyes with previous LASIK for myopia [Abstract]. Clinical and Experience Ophthalmology Annual Scientific Congress, October 2015 (Auckland, New Zealand) (Link)
  3. Shu DY, Ong K, Lovicu FJ. Histopathology of anterior subcapsular cataract in a patient with atopic dermatitis [Abstract]. Clinical and Experience Ophthalmology Annual Scientific Congress, October 2015 (Auckland, New Zealand) (Link)
  4. Shu DY, Ong K, Lovicu FJ. Histopathology of anterior subcapsular cataract in a patient with atopic dermatitis [Abstract]. The EMT International Association (TEMTIA) VII Meeting, October 2015 (Melbourne, Australia) (Link)
  5. Shu DY, Ong K, Lovicu FJ. Bone morphogenetic protein (BMP)-7 modulates TGFβ-induced epithelial-mesenchymal transition (EMT) of lens epithelial cells in a dose-dependent manner [Abstract]. ARVO Annual Meeting, May 2016 (Seattle, Washington), won the ARVO Members-in-training Outstanding Poster Award in the Lens section (Link)
  6. Shu DY, Lovicu FJ. EGFR signalling promotes TGFβ-dependent epithelial-mesenchymal transition (EMT) in lens [Abstract]. ARVO Annual Meeting, May 2017 (Baltimore, Maryland) (Link)
  7. Shu DY, Lovicu FJ. Inhibition of EGFR signaling is a novel approach to prevention of posterior capsular opacification [Abstract]. American Academy of Optometry Annual Meeting, October 2017 (Chicago, Illinois), selected as one of the top ten most newsworthy abstracts by the Academy Communications Committee to present a talk at the American Academy of Optometry Press Conference (Link)
  8. Shu DY, Lovicu FJ. EGFR signalling augments TGFβ-induced epithelial-mesenchymal transition (EMT) in lens epithelial cells [Abstract]. Australian Society for Medical Research (ASMR) 56th National Scientific Meeting, November 2017 (Charles Perkins Centre, University of Sydney, Australia) (Link)
  9. Shu DY, Lovicu FJ. Inhibition of EGFR signaling is a novel approach to prevention of cataract and posterior capsular opacification [Abstract]. Bosch Young Investigators Annual Symposium, November 2017 (University of Sydney) (Link)
  10. Shu DY, Lovicu FJ. EGF exacerbates TGF-beta-induced epithelial-mesenchymal transition in the ocular lens: a novel mechanism in cataract formation [Abstract]. ComBio2018, September 2018 (Sydney, Australia)

 

Collaborations

  1. Lovicu F, Wojciechowski M, Das S, Zhao G, Shu DY. Regulating TGF beta-mediated EMT leading to cataract [Abstract] Japanese Society of Ophthalmology Meeting, April 2016 (Sapporo, Japan) (Link)
  2. Lovicu FJ, Das S, Zhao G, Wojciechowski M, Shu DY. Regulation of TGFβ-induced EMT leading to fibrotic forms of cataract [Abstract] Asia-ARVO Annual Meeting, February 2017 (Brisbane, Australia) (Link)